82 related articles for article (PubMed ID: 7565955)
1. Mitochondrial toxicity--new adverse drug effects.
Swartz MN
N Engl J Med; 1995 Oct; 333(17):1146-8. PubMed ID: 7565955
[No Abstract] [Full Text] [Related]
2. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
McKenzie R; Fried MW; Sallie R; Conjeevaram H; Di Bisceglie AM; Park Y; Savarese B; Kleiner D; Tsokos M; Luciano C
N Engl J Med; 1995 Oct; 333(17):1099-105. PubMed ID: 7565947
[TBL] [Abstract][Full Text] [Related]
3. Severe toxicity of fialuridine (FIAU).
Lewis W; Perrino FW
N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598881
[No Abstract] [Full Text] [Related]
4. Severe toxicity of fialuridine (FIAU).
Gordon M
N Engl J Med; 1996 Apr; 334(17):1136-7; author reply 1137-8. PubMed ID: 8598883
[No Abstract] [Full Text] [Related]
5. NIH, FDA seek lessons from hepatitis B drug trial deaths.
Macilwain C
Nature; 1993 Jul; 364(6435):275. PubMed ID: 8332178
[No Abstract] [Full Text] [Related]
6. NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned.
Marwick C
JAMA; 1994 Jul; 272(1):9-11. PubMed ID: 8007087
[No Abstract] [Full Text] [Related]
7. Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax).
Lewis W; Griniuviene B; Tankersley KO; Levine ES; Montione R; Engelman L; de Courten-Myers G; Ascenzi MA; Hornbuckle WE; Gerin JL; Tennant BC
Lab Invest; 1997 Jan; 76(1):77-87. PubMed ID: 9010451
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
[TBL] [Abstract][Full Text] [Related]
9. Severe toxicity of fialuridine (FIAU).
Prince AM
N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598882
[No Abstract] [Full Text] [Related]
10. Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.
Stevenson W; Gaffey M; Ishitani M; McCullough C; Dickson R; Caldwell S; Lobo P; Pruett T
Transplant Proc; 1995 Feb; 27(1):1219-21. PubMed ID: 7878856
[No Abstract] [Full Text] [Related]
11. Hepatitis study. Drug trial deaths deemed unavoidable.
Marshall E
Science; 1994 Jun; 264(5165):1530. PubMed ID: 8202706
[No Abstract] [Full Text] [Related]
12. Concern grows over reaction to deaths in clinical trials.
Macilwain C
Nature; 1994 May; 369(6478):268. PubMed ID: 8183354
[No Abstract] [Full Text] [Related]
13. Mitochondrial injury. Lessons from the fialuridine trial.
Honkoop P; Scholte HR; de Man RA; Schalm SW
Drug Saf; 1997 Jul; 17(1):1-7. PubMed ID: 9258627
[TBL] [Abstract][Full Text] [Related]
14. Deaths in US fialuridine trial.
Brahams D
Lancet; 1994 Jun; 343(8911):1494-5. PubMed ID: 7911188
[No Abstract] [Full Text] [Related]
15. US health agencies at odds over trial deaths.
Macilwain C
Nature; 1994 Jun; 369(6480):433. PubMed ID: 8202125
[No Abstract] [Full Text] [Related]
16. Severe toxicity of fialuridine (FIAU).
Josephson L
N Engl J Med; 1996 Apr; 334(17):1135-6; author reply 1137-8. PubMed ID: 8598880
[No Abstract] [Full Text] [Related]
17. Histopathologic changes associated with fialuridine hepatotoxicity.
Kleiner DE; Gaffey MJ; Sallie R; Tsokos M; Nichols L; McKenzie R; Straus SE; Hoofnagle JH
Mod Pathol; 1997 Mar; 10(3):192-9. PubMed ID: 9071726
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU).
Colacino JM
Antiviral Res; 1996 Mar; 29(2-3):125-39. PubMed ID: 8739593
[TBL] [Abstract][Full Text] [Related]
19. Trial deaths prompt tighter rules.
Macilwain C
Nature; 1993 Nov; 366(6453):294. PubMed ID: 8247116
[No Abstract] [Full Text] [Related]
20. Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
Miller JP; Mintz PD
Transfus Sci; 1994 Sep; 15(3):299-302. PubMed ID: 10161259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]